Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.04 | 18.55 |
| PEG Ratio (TTM) | 0.00 | -0.07 |
| P/S Ratio (TTM) | 0.71 | 0.51 |
| P/B Ratio (TTM) | 0.03 | 1.34 |
| P/FCF Ratio (TTM) | -0.04 | 13.72 |
| Price to 5YR AVG Earnings Ratio | N/A | 14.76 |
| Price to 5YR AVG FCF Ratio | N/A | 58.91 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -29.67% | 4.19% |
| ROE (TTM) | -54.53% | 9.95% |
| Net Profit Margin (TTM) | -1,210.57% | 1.39% |
| ROIC 5YR AVG | N/A | 11.94% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -44.91% | N/A | N/A |
| Revenue | 212.55% | N/A | N/A |
| Net Income | -50.60% | N/A | N/A |
| Cash Flow | -18.69% | N/A | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.66 | 1.98 |
| Quick Ratio (TTM) | 2.24 | 1.16 |
| D/E Ratio (TTM) | 1.12 | 0.52 |
| Interest Coverage (TTM) | -3.48 | 4.23 |
| Piotroski F-Score | 3 | 7 |
| Altman Z-Score | N/A | 3.80 |
| LTL to 5YR AVG FCF | N/A | 18.04 |
| Shares Outstanding Growth 5YR AVG | N/A | 0.95% |